ProfileGDS5822 / ILMN_1251714
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 3% 44% 31% 30% 37% 31% 22% 34% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16.63
GSM1276600PDAC Late Ablation Control 221.644
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.931
GSM1276603PDAC Late Ablation 215.130
GSM1276604PDAC Late Ablation 318.137
GSM1303940PDAC Late Ablation_anti-CTLA4 115.731
GSM1303941PDAC Late Ablation_anti-CTLA4 211.622
GSM1303942PDAC Late Ablation_anti-CTLA4 316.334